Jacobs Levy Equity Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jacobs Levy Equity Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-861,801	Closed	-$9.53M	–	1096
2023 Q2	$9.53M	Sell	861,801 -61,568	-7%	-$858K	0.05%	283
2023 Q1	$12.4M	Buy	923,369 +262	+0%	+$4.53K	0.08%	253
2022 Q4	$11.4M	Buy	923,107 +142,162	+18%	+$2.01M	0.08%	263
2022 Q3	$10.9M	Buy	780,945 +135,254	+21%	+$2.18M	0.09%	246
2022 Q2	$8.92M	Buy	645,691 +53,387	+9%	+$855K	0.07%	300
2022 Q1	$9.64M	Buy	592,304 +3,382	+0.6%	+$53K	0.06%	299
2021 Q4	$9.59M	Buy	588,922 +54,746	+10%	+$923K	0.06%	309
2021 Q3	$7.93M	Sell	534,176 -79,712	-13%	-$1.28M	0.05%	349
2021 Q2	$12.3M	Buy	613,888 +81,786	+15%	+$1.62M	0.08%	255
2021 Q1	$12.3M	Buy	532,102 +52,378	+11%	+$1.46M	0.09%	248
2020 Q4	$11.8M	Buy	479,724 +132,478	+38%	+$4.39M	0.1%	226
2020 Q3	$14.4M	Buy	347,246 +297,789	+602%	+$13.7M	0.15%	156
2020 Q2	$2.37M	Buy	49,457 +5,455	+12%	+$421K	0.03%	495
2020 Q1	$2.77M	Sell	44,002 -340	-0.8%	-$30.6K	0.04%	416
2019 Q4	$5.5M	Buy	44,342 +4,050	+10%	+$363K	0.05%	351
2019 Q3	$2.67M	Buy	+40,292	New	+$2.71M	0.03%	454
2016 Q3	–	Sell	-8,120	Closed	-$1.16M	–	1159
2016 Q2	$1.16M	Sell	8,120 -4,920	-38%	-$717K	0.02%	545
2016 Q1	$1.68M	Buy	+13,040	New	+$1.54M	0.04%	450

Other funds holding ICPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jacobs Levy Equity Management's ICPT Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 861,801 shares — an estimated $9.53M sold.

Jacobs Levy Equity Management first reported a position in ICPT in Q1 2016 and held it in 18 quarters. The position peaked at $14.4M in Q3 2020. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

Jacobs Levy Equity Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 861,801 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $9.53M.
Jacobs Levy Equity Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 18 quarters.
Jacobs Levy Equity Management's Intercept Pharmaceuticals, Inc. position peaked at $14.4M in Q3 2020.
146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.